Step Forward with Zepbound®(tirzepatide) injection
true
Once-weekly Zepbound is a prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems to lose excess body weight and keep it off. Zepbound may also help improve moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. It should be used with a reduced-calorie diet and increased physical activity.
See Indications and Safety Summary with Warnings including Limitation of Use below.
2.5 mg is the starting dose and is not an approved maintenance dose.
See Indications and Safety Summary with Warnings including Limitation of Use below.
2.5 mg is the starting dose and is not an approved maintenance dose.
true
Choose your condition
LEARN MORE ABOUT ZEPBOUND
Weight Management
Obstructive Sleep Apnea
Select Safety Information
Warning:
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Zepbound and medicines that work like Zepbound caused thyroid tumors, including thyroid cancer. It is not known if Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Zepbound if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Zepbound and medicines that work like Zepbound caused thyroid tumors, including thyroid cancer. It is not known if Zepbound will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Zepbound if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
card, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
card, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
